Advertisements

CorMedix Inc (CRMD) Stock Quote

Detailed Quote for CorMedix Inc (CRMD)
$ 0.5825   -0.0265 (-4.35%) Volume: 688.61k 4:10 PM EDT Oct 23, 2017
After Hours:  $ 0.582   -0.0005 (-0.09%) Volume: 1,000 4:09 PM EDT Oct 23, 2017
Today 5d 1m 3m 1y more
Last Price
0.5825
Change $
0.0265
Change %
4.35%
Tick
  
Bid
0.5802
Bid Size
2,500
Ask
0.5825
Ask Size
500
Open
0.6179
High
0.6337
Low
0.58021
Prev Close
0.609
Last Trade
4:10
Volume
688.61k
52 Wk Hi
2.48000001
52 Wk Low
0.321999996
Market Cap
35.96m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
61,727,639
EPS (TTM)
-0.680000007
PE Ratio
N/A
Exchange
NYSE American
News and Media for CorMedix Inc (CRMD)
Sector News | Topic News
News for CorMedix Inc (CRMD)
Thu, Sep 28, 2017
8:05 AM CorMedix Inc. to Present at The MicroCap Conference - ACCESSWIRE
Mon, Sep 25, 2017
9:11 AM Premarket analyst action - healthcare - SeekingAlpha
8:05 AM CorMedix Inc. Relocates Corporate Headquarters - ACCESSWIRE
Thu, Sep 21, 2017
12:15 PM CorMedix Inc. to Present at The MicroCap Conference on October 5th in New York City at the Essex House - ACCESSWIRE
Tue, Sep 12, 2017
8:17 AM CorMedix Inc. to Present at the Anti-Infectives Rx Conference - ACCESSWIRE
Thu, Sep 07, 2017
4:05 PM CorMedix Inc. Presents Data Demonstrating Antimicrobial Activity of Taurolidine Against Potentially Deadly Fungal Pathogen Candida auris - ACCESSWIRE
Tue, Sep 05, 2017
4:45 PM CorMedix Inc. to Present at 2017 Rodman & Renshaw 19th Annual Global Investment Conference - ACCESSWIRE
Fri, Aug 25, 2017
4:07 PM CorMedix Inc. Announces a Change to its Senior Leadership - ACCESSWIRE
Thu, Aug 17, 2017
9:17 AM CorMedix, Inc. Awarded NIH Grant to Develop Advanced Antimicrobial Hydrogels for the Treatment and Prevention of Potentially Life-Threatening Infections in Severe Burns - ACCESSWIRE
Thu, Aug 10, 2017
9:54 AM R&R trims price targets for Cormedix and Synergy Pharma - SeekingAlpha
8:41 AM CorMedix beats by $0.06, misses on revenue - SeekingAlpha
Wed, Aug 09, 2017
10:57 PM CorMedix's (CRMD) CEO Khoso Baluch on Q2 2017 Results - Earnings Call Transcript - SeekingAlpha
4:10 PM CorMedix Inc. Reports Second Quarter Financial Results and Provides Business Update - ACCESSWIRE
4:10 PM CorMedix Inc. Reports Second Quarter Financial Results and Provides Business Update - ACCESSWIRE
12:03 PM Investor Network: CorMedix Inc. to Host Earnings Call - ACCESSWIRE
12:00 PM Investor Network: CorMedix Inc. to Host Earnings Call - ACCESSWIRE
Mon, Aug 07, 2017
8:47 AM CorMedix Inc. Appoints Gary Gelbfish, M.D., to Board of Directors - ACCESSWIRE
Fri, Aug 04, 2017
2:51 PM CorMedix Inc. to Report Second Quarter 2017 Financial Results and Provide Business Update - ACCESSWIRE
Wed, Aug 02, 2017
9:07 AM CorMedix Inc. Provides Update on Neutrolin(R) Ongoing Phase 3 Clinical Trial Following Favorable FDA Correspondence - ACCESSWIRE
Thu, Jul 13, 2017
12:11 PM CorMedix (CRMD) Investor Presentation (R&D Day 2017) - Slideshow - SeekingAlpha
More News for CRMD >>

Tags for CorMedix Inc

Research stocks or mutual funds related to CorMedix Inc by keywords or tags. Find companies that have a similar focus to CRMD. The keywords below have been associated to CRMD by either user submission or electronic means.